IDEAYA Biosciences, Inc. (IDYA) vs Telix Pharmaceuticals Limited (TLX)
- IDEAYA Biosciences, Inc. IDYA 32.85 −2.95%
- Telix Pharmaceuticals Limited TLX 10.69 +1.14%
IDEAYA Biosciences, Inc. and Telix Pharmaceuticals Limited are both Biotechnology companies. Telix Pharmaceuticals Limited is the larger, with a market value of $3.6B against $3.3B — 1.1× the size. Across the 9 metrics below, Telix Pharmaceuticals Limited leads on 5 and IDEAYA Biosciences, Inc. on 4.
Valuation
Profitability
| Metric | IDYA | TLX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | — | 65.16% |
| Operating margin | (92.66%) | — | 0.00% |
| Net margin | (74.75%) | — | 0.00% |
| Free cash flow margin | (48.64%) | 0.00% | 0.00% |
| Return on equity | (16.22%) | 0.00% | (56.36%) |
| Return on assets | (14.89%) | 0.00% | (48.04%) |
| Return on invested capital | (36.65%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack